NB International Equity Income (S:0P0001RDBU)
20.25
+0.58
(+2.97%)
USD |
Nov 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 29, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| HSBC Holdings Plc | 3.15% | 15.60 | -2.16% |
| Allianz SE | 3.07% | 458.18 | -0.42% |
| BHP Group Ltd. | 3.04% | 30.50 | 3.39% |
| Novartis AG | 2.86% | 138.48 | -0.28% |
| Rio Tinto Plc | 2.68% | 80.12 | -3.15% |
| AXA SA | 2.62% | 48.02 | -0.11% |
| Zurich Insurance Group AG | 2.59% | 759.88 | 0.70% |
| Enel SpA | 2.59% | 10.46 | 4.81% |
| Banco Bilbao Vizcaya Argentaria SA | 2.51% | 22.55 | -3.43% |
|
GlaxoSmithKline
|
2.44% | -- | -- |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |